A growing body of clinical evidence is now showing that medical cannabis may have analgesic,
appetite-modulatory, immunosuppressant, anti-emetic, neuroleptic or antineoplastic effects
among other therapeutic benefits. The variety that will work best for your patient depends
on many factors – ultimately the right match will depend on the patient’s individual physical
and mental responses to the multiple variations of the medication.
Health Canada has published a document entitled ‘Information for Health Care Professionals’ in which they discuss the potential therapeutic uses for medicinal cannabis:
Read Health Canada’s Official Documents Here
MedReleaf is the first and only ISO 9001:2008 certified medical cannabis producer in Canada,
which means that our superior QA practices are formally accredited by the prestigious,
international governing authority. Our medical cannabis is produced using clean-room
technologies, and our facility is designed to exceed Good Production Practices (GPP). Our
monitoring begins at seed selection and continues throughout the growing, harvesting,
trimming, drying, and packaging phases.
MedReleaf is setting the Medical Grade Standard™ for product quality and safety because quality assurance is at the core of every plant that we grow and each shipment that we make. Our Quality Assurance team is comprised of seasoned individuals with many years of experience in areas such as the manufacturing of biological implants and the implementation of cutting-edge laboratory technologies.. These leading practices help to focus MedReleaf on patient safety, with an emphasis on the reporting, analysis, and prevention of medical errors
At MedReleaf, we understand that health care providers depend on evidence to draw medical conclusions. This is why we are working to bring evidence-based results to the world. In partnership with Tikun Olam, MedReleaf is currently involved in a variety of scientific and clinical studies at world-class hospitals and research institutions.Learn More
Avidekel, Midnight, Eran Almog; these are just some of the exclusive varieties exclusive varieties that are only available in Canada through MedReleaf. These unique varieties have been consistently grown and used to treat thousands of patients over 12 years, and they are some of the most researched varieties in the world.Learn More
Cannabinoids exert many of their pharmacological effects by interacting with and modulating
the human endocannabinoid system. This integrated system is comprised of a family of
cannabinoid receptors, their endogenous activators (ligands), enzymes and transporters.
There are two types of cannabinoid receptors, CB1 and CB2. In addition, cannabinoids interact with other important neurotransmitter and neuromodulatory systems as well as TRP Channels.
The far-reaching pharmacology of cannabinoids explains why they hold such promise in diverse therapeutic areas.